303 related articles for article (PubMed ID: 17065344)
1. Recognition of HLA class I-restricted beta-cell epitopes in type 1 diabetes.
Ouyang Q; Standifer NE; Qin H; Gottlieb P; Verchere CB; Nepom GT; Tan R; Panagiotopoulos C
Diabetes; 2006 Nov; 55(11):3068-74. PubMed ID: 17065344
[TBL] [Abstract][Full Text] [Related]
2. Identification of Novel HLA-A*0201-restricted epitopes in recent-onset type 1 diabetic subjects and antibody-positive relatives.
Standifer NE; Ouyang Q; Panagiotopoulos C; Verchere CB; Tan R; Greenbaum CJ; Pihoker C; Nepom GT
Diabetes; 2006 Nov; 55(11):3061-7. PubMed ID: 17065343
[TBL] [Abstract][Full Text] [Related]
3. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes.
Pinkse GG; Tysma OH; Bergen CA; Kester MG; Ossendorp F; van Veelen PA; Keymeulen B; Pipeleers D; Drijfhout JW; Roep BO
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18425-30. PubMed ID: 16339897
[TBL] [Abstract][Full Text] [Related]
4. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.
Martinuzzi E; Novelli G; Scotto M; Blancou P; Bach JM; Chaillous L; Bruno G; Chatenoud L; van Endert P; Mallone R
Diabetes; 2008 May; 57(5):1312-20. PubMed ID: 18305140
[TBL] [Abstract][Full Text] [Related]
5. Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers.
Unger WW; Velthuis J; Abreu JR; Laban S; Quinten E; Kester MG; Reker-Hadrup S; Bakker AH; Duinkerken G; Mulder A; Franken KL; Hilbrands R; Keymeulen B; Peakman M; Ossendorp F; Drijfhout JW; Schumacher TN; Roep BO
J Autoimmun; 2011 Nov; 37(3):151-9. PubMed ID: 21636247
[TBL] [Abstract][Full Text] [Related]
6. HLA class I epitope discovery in type 1 diabetes.
van Endert P; Hassainya Y; Lindo V; Bach JM; Blancou P; Lemonnier F; Mallone R
Ann N Y Acad Sci; 2006 Oct; 1079():190-7. PubMed ID: 17130554
[TBL] [Abstract][Full Text] [Related]
7. CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes.
Mallone R; Martinuzzi E; Blancou P; Novelli G; Afonso G; Dolz M; Bruno G; Chaillous L; Chatenoud L; Bach JM; van Endert P
Diabetes; 2007 Mar; 56(3):613-21. PubMed ID: 17327428
[TBL] [Abstract][Full Text] [Related]
8. Immunology of Diabetes Society T-Cell Workshop: HLA class I tetramer-directed epitope validation initiative T-Cell Workshop Report-HLA Class I Tetramer Validation Initiative.
Mallone R; Scotto M; Janicki CN; James EA; Fitzgerald-Miller L; Wagner R; Gottlieb P; Thorpe J; Jospe N; Durinovic-Bellò I; Boitard C; Lou O; Dayan CM; Wong FS;
Diabetes Metab Res Rev; 2011 Nov; 27(8):720-6. PubMed ID: 22069251
[TBL] [Abstract][Full Text] [Related]
9. Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays.
Wu X; Xu X; Gu R; Wang Z; Chen H; Xu K; Zhang M; Hutton J; Yang T
Autoimmunity; 2012 Mar; 45(2):176-85. PubMed ID: 22260783
[TBL] [Abstract][Full Text] [Related]
10. Ran, a small GTPase gene, encodes cytotoxic T lymphocyte (CTL) epitopes capable of inducing HLA-A33-restricted and tumor-reactive CTLs in cancer patients.
Azuma K; Sasada T; Takedatsu H; Shomura H; Koga M; Maeda Y; Yao A; Hirai T; Takabayashi A; Shichijo S; Itoh K
Clin Cancer Res; 2004 Oct; 10(19):6695-702. PubMed ID: 15475460
[TBL] [Abstract][Full Text] [Related]
11. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
Serreze DV; Marron MP; Dilorenzo TP
Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
[TBL] [Abstract][Full Text] [Related]
12. Humoral and cellular immune responses to proinsulin in adults with newly diagnosed type 1 diabetes.
Narendran P; Williams AJ; Elsegood K; Leech NJ; Dayan CM
Diabetes Metab Res Rev; 2003; 19(1):52-9. PubMed ID: 12592644
[TBL] [Abstract][Full Text] [Related]
13. Cloned T cells from a recent onset IDDM patient reactive with insulin B-chain.
Schloot NC; Willemen S; Duinkerken G; de Vries RR; Roep BO
J Autoimmun; 1998 Apr; 11(2):169-75. PubMed ID: 9650096
[TBL] [Abstract][Full Text] [Related]
14. In vivo cytotoxicity of insulin-specific CD8+ T-cells in HLA-A*0201 transgenic NOD mice.
Jarchum I; Baker JC; Yamada T; Takaki T; Marron MP; Serreze DV; DiLorenzo TP
Diabetes; 2007 Oct; 56(10):2551-60. PubMed ID: 17620420
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T cells to an epitope in the islet autoantigen IA-2 are not disease-specific.
Takahashi K; Honeyman MC; Harrison LC
Clin Immunol; 2001 Jun; 99(3):360-4. PubMed ID: 11358432
[TBL] [Abstract][Full Text] [Related]
16. Altered peptide ligands of islet autoantigen Imogen 38 inhibit antigen specific T cell reactivity in human type-1 diabetes.
Geluk A; van Meijgaarden KE; Roep BO; Ottenhoff TH
J Autoimmun; 1998 Aug; 11(4):353-61. PubMed ID: 9776713
[TBL] [Abstract][Full Text] [Related]
17. Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals.
Berthelot L; Laplaud DA; Pettré S; Ballet C; Michel L; Hillion S; Braudeau C; Connan F; Lefrère F; Wiertlewski S; Guillet JG; Brouard S; Choppin J; Soulillou JP
Eur J Immunol; 2008 Jul; 38(7):1889-99. PubMed ID: 18506883
[TBL] [Abstract][Full Text] [Related]
18. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library.
Wong FS; Karttunen J; Dumont C; Wen L; Visintin I; Pilip IM; Shastri N; Pamer EG; Janeway CA
Nat Med; 1999 Sep; 5(9):1026-31. PubMed ID: 10470079
[TBL] [Abstract][Full Text] [Related]
19. Identification of HLA-A33-restricted CMV pp65 epitopes as common targets for CD8(+) CMV-specific cytotoxic T lymphocytes.
Lim JB; Provenzano M; Kwon OH; Bettinotti M; Caruccio L; Nagorsen D; Stroncek D
Exp Hematol; 2006 Mar; 34(3):296-307. PubMed ID: 16543064
[TBL] [Abstract][Full Text] [Related]
20. Identification of a beta-cell-specific HLA class I restricted epitope in type 1 diabetes.
Panagiotopoulos C; Qin H; Tan R; Verchere CB
Diabetes; 2003 Nov; 52(11):2647-51. PubMed ID: 14578281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
